Opko Health share price today

(OPK)

Opko Health share price is $1.47 & ₹125.91 as on 1 Jan 2025, 2.30 'hrs' IST

$1.47

Market is closed - opens 8 PM, 02 Jan 2025

View live Opko Health share price in Dollar and Rupees. Guide to invest in Opko Health from India. Also see the sentimental analysis on Indian investors investing in Opko Health. Get details on the Indian mutual funds that are investing in Opko Health. Get Analyst recommendations and forecasts along with all the Opko Health's financials.

Opko Health share price movements

Today's Low: $1.47
Today's High: $1.50
$1.47
0.34%
Downside
Day's Volatility :2.33%
Upside
2.0%
52 Weeks Low: $0.85
52 Weeks High: $1.76
$1.47
42.07%
Downside
52 Weeks Volatility :51.61%
Upside
16.48%

Opko Health Returns

Period	Opko Health, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-2.65%	-10.0%	0.0%
6 Months	16.67%	-4.7%	0.0%
1 Year	-2.0%	-0.9%	0.0%
3 Years	-70.18%	-2.4%	-21.2%

Opko Health Key Statistics

in dollars & INR

Previous Close	$1.47
Open	$1.47
Today's High	$1.5
Today's Low	$1.465
Market Capitalization	$989.0M
Today's Volume	$3.0M
52 Week High	$1.76
52 Week Low	$0.8516
Revenue TTM	$711.4M
EBITDA	$-209.4M
Earnings Per Share (EPS)	$-0.19
Profit Margin	-18.8%
Quarterly Earnings Growth YOY	0.19%
Return On Equity TTM	-9.39%

How to invest in Opko Health from India?

It is very easy for Indian residents to invest directly in Opko Health from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Opko Health stock in both Indian Rupees (INR) and US Dollars (USD). Search for Opko Health or OPK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Opko Health or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Opko Health shares which would translate to 0.583 fractional shares of Opko Health as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Opko Health, in just a few clicks!

Returns in Opko Health for Indian investors in Rupees

Investment Value

₹1,00,000

Opko Health investment value today

Current value as on today

₹1,00,867

Returns

₹867

(+0.87%)

Returns from Opko Health Stock

₹2,000 (-2%)

Dollar Returns

₹2,867 (+2.87%)

Indian investors sentiment towards Opko Health

18%

Period: Oct 3, 2024 to Jan 1, 2025. Change in 30 Days versus previous period

Search volume for Opko Health on INDmoney from India has grown in the last 30 days as on Jan 2, 2025. 18% more investors are searching Opko Health in the last 30 days versus the previous period.

Global Institutional Holdings in Opko Health

Rubric Capital Management LP
7.24%
BlackRock Inc
4.35%
Vanguard Group Inc
4.34%
State Street Corp
1.30%
Geode Capital Management, LLC
1.24%
Amvescap Plc.
0.90%

Analyst Recommendation on Opko Health

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Opko Health(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Opko Health

What analysts predicted

Upside of 169.27%

Current:

$1.47

Target:

$3.96

Insights on Opko Health

Price Movement
In the last 3 years, OPK stock has moved down by -69.4%
Decreasing Revenue
Revenue is down for the last 2 quarters, 182.18M → 173.63M (in $), with an average decrease of 4.7% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -81.83M → 24.89M (in $), with an average increase of 417.8% per quarter
OPK vs DHR (1 yr)
In the last 1 year, Opko Health, Inc. has experienced a drawdown of -6.4%, however Danaher Corp. resisted the overall trend and outperformed by 4.2%
OPK vs A (3 yr)
In the last 3 years, Opko Health, Inc. has experienced a drawdown of -69.4%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 39.2%
Price to Sales
ForOPK every $1 of sales, investors are willing to pay $1.5, whereas for Danaher Corp., the investors are paying $7.1 for every $1 of sales.

Opko Health Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$990.3M	↑ 2.51%
Net Income	$-153.0M	↓ 49.88%
Net Profit Margin	-15.45%	↑ 16.15%

	FY19	Y/Y Change
Revenue	$901.9M	↓ 8.93%
Net Income	$-312.0M	↑ 103.92%
Net Profit Margin	-34.59%	↓ 19.14%

	FY20	Y/Y Change
Revenue	$1.4B	↑ 59.15%
Net Income	$30.6M	↓ 109.8%
Net Profit Margin	2.13%	↑ 36.72%

	FY21	Y/Y Change
Revenue	$1.8B	↑ 23.64%
Net Income	$-29.5M	↓ 196.45%
Net Profit Margin	-1.66%	↓ 3.79%

	FY22	Y/Y Change
Revenue	$1.0B	↓ 43.42%
Net Income	$-328.0M	↑ 1011.86%
Net Profit Margin	-32.66%	↓ 31.0%

	FY23	Y/Y Change
Revenue	$863.5M	↓ 14.01%
Net Income	$-188.9M	↓ 42.42%
Net Profit Margin	-21.87%	↑ 10.79%

	Q2 FY23	Q/Q Change
Revenue	$265.4M	↑ 11.71%
Net Income	$-19.6M	↑ 7.91%
Net Profit Margin	-7.4%	↑ 0.26%

	Q3 FY23	Q/Q Change
Revenue	$178.6M	↓ 32.71%
Net Income	$-84.5M	↑ 330.24%
Net Profit Margin	-47.31%	↓ 39.91%

	Q4 FY23	Q/Q Change
Revenue	$181.9M	↑ 1.85%
Net Income	$-66.5M	↓ 21.29%
Net Profit Margin	-36.56%	↑ 10.75%

	Q1 FY24	Q/Q Change
Revenue	$173.7M	↓ 4.52%
Net Income	$-81.8M	↑ 23.05%
Net Profit Margin	-47.12%	↓ 10.56%

	Q2 FY24	Q/Q Change
Revenue	$182.2M	↑ 4.89%
Net Income	$-10.3M	↓ 87.41%
Net Profit Margin	-5.66%	↑ 41.46%

	Q3 FY24	Q/Q Change
Revenue	$173.6M	↓ 4.7%
Net Income	$24.9M	↓ 341.53%
Net Profit Margin	14.33%	↑ 19.99%

	FY18	Y/Y Change
Profit	$385.7M	↑ 11.51%

	FY19	Y/Y Change
Profit	$329.4M	↓ 14.6%

	FY20	Y/Y Change
Profit	$541.0M	↑ 64.24%

	FY21	Y/Y Change
Profit	$581.5M	↑ 7.49%

	FY22	Y/Y Change
Profit	$288.2M	↓ 50.44%

	FY23	Y/Y Change
Profit	$318.1M	↑ 10.38%

	Q2 FY23	Q/Q Change
Profit	$126.5M	↑ 27.37%

	Q3 FY23	Q/Q Change
Profit	$47.7M	↓ 62.29%

	Q4 FY23	Q/Q Change
Profit	$23.2M	↓ 51.36%

	Q1 FY24	Q/Q Change
Profit	$20.6M	↓ 11.07%

	Q2 FY24	Q/Q Change
Profit	$31.2M	↑ 51.38%

	Q3 FY24	Q/Q Change
Profit	$40.1M	↑ 28.48%

	FY18	Y/Y Change
Operating Cash Flow	$-109.1M	↑ 18.53%
Investing Cash Flow	$-26.1M	↓ 44.03%
Financing Cash Flow	$140.9M	↑ 130.84%

	FY19	Y/Y Change
Operating Cash Flow	$-172.5M	↑ 58.07%
Investing Cash Flow	$-13.3M	↓ 49.19%
Financing Cash Flow	$175.2M	↑ 24.37%

	FY20	Y/Y Change
Operating Cash Flow	$39.5M	↓ 122.88%
Investing Cash Flow	$-18.3M	↑ 38.11%
Financing Cash Flow	$-35.1M	↓ 120.02%

	FY21	Y/Y Change
Operating Cash Flow	$38.3M	↓ 2.89%
Investing Cash Flow	$35.9M	↓ 296.15%
Financing Cash Flow	$-10.4M	↓ 70.49%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-365.0K	↓ 98.39%
Investing Cash Flow	$-5.5M	↓ 28.85%
Financing Cash Flow	$3.5M	↓ 126.39%

Opko Health Technicals Summary

Sell

Neutral

Buy

Opko Health is currently in a neutral trading position according to technical analysis indicators.

Opko Health Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Opko Health, Inc.	-6.96%	16.67%	-2.0%	-70.18%	-1.34%
Idexx Laboratories, Inc.	-4.32%	-14.93%	-22.73%	-34.48%	54.89%
Agilent Technologies Inc.	-3.55%	6.31%	2.42%	-14.15%	58.38%
Thermo Fisher Scientific, Inc.	-2.66%	-3.68%	-1.62%	-19.33%	60.0%
Danaher Corp.	-4.7%	-4.05%	-0.55%	-27.3%	48.47%
Iqvia Holdings Inc.	-2.03%	-5.57%	-10.68%	-28.17%	26.78%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Opko Health, Inc.	NA	NA	-2.87	0.0	-0.09	-0.09	NA	2.06
Idexx Laboratories, Inc.	39.83	39.83	4.34	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	30.33	30.33	2.28	5.56	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	32.58	32.58	1.98	21.7	0.13	0.05	0.0	128.08
Danaher Corp.	43.31	43.31	3.07	7.5	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	25.86	25.86	1.04	11.11	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Opko Health, Inc.	Buy	$989.0M	-1.34%	NA	-18.8%
Idexx Laboratories, Inc.	Buy	$33.9B	54.89%	39.83	22.53%
Agilent Technologies Inc.	Buy	$38.4B	58.38%	30.33	21.75%
Thermo Fisher Scientific, Inc.	Buy	$199.0B	60.0%	32.58	14.48%
Danaher Corp.	Buy	$165.8B	48.47%	43.31	16.39%
Iqvia Holdings Inc.	Buy	$35.7B	26.78%	25.86	9.17%

About Opko Health

opko health is a diversified healthcare company that seeks to establish industry leading positions in large, rapidly growing markets. our diagnostics business includes bioreference laboratories, the nation's third largest clinical laboratory with a core genetic testing business and a 400 person sales and marketing team to drive growth and leverage new products, including the 4kscore® prostate cancer test and the claros® 1 in office immunoassay platform. our pharmaceutical business features rayaldee, an fda approved treatment for shpt in stage 3-4 ckd patients with vitamin d insufficiency (launched in november 2016), varubitm for chemotherapy induced nausea and vomiting (oral formulation launched by partner tesaro and iv formulation pending fda approval), opk88004, a once or twice weekly oxyntomodulin for type 2 diabetes and obesity, in phase 2 clinical trials, among the new class of glp-1 glucagon receptor dual agonists, and opk88003, a selective androgen receptor modulator for benig

Organization	Opko Health
Employees	3930
CEO	Dr. Phillip Frost Ph.D.
Industry	Health Technology

Management People of Opko Health

Name	Title
Dr. Phillip Frost Ph.D.	Chairman & CEO
Dr. Jane H. Hsiao M.B.A., Ph.D.	Vice Chairman & Chief Technical Officer
Dr. Elias Adam Zerhouni M.D.	President & Vice Chairman
Mr. Adam E. Logal	Senior VP, CFO, Chief Accounting Officer & Treasurer
Mr. Steven D. Rubin Esq., J.D.	Executive VP of Administration & Director
Dr. Akhtar Ashfaq FACP, FASN, M.D.	Senior Vice President of Clinical Research & Development and Medical Affairs - Opko Renal
Dr. Gary J. Nabel M.D., Ph.D.	Chief Innovation Officer & Director
Mr. Giovanni Abbadessa M.D., Ph.D.	Chief Medical Officer
Dr. Charles W. Bishop	Chief Executive Officer of OPKO Renal
Dr. Antonio F. Cruz	President of Transition Therapeutics

Important FAQs about investing in Opko Health from India :

What is Opko Health share price today?

Opko Health share price today stands at $1.47, Open: $1.47 ; Previous Close: $1.47 ; High: $1.50 ; Low: $1.47 ; 52 Week High: $1.76 ; 52 Week Low: $0.85. The stock opens at $1.47, after a previous close of $1.47. The stock reached a daily high of $1.50 and a low of $1.47, with a 52-week high of $1.76 and a 52-week low of $0.85.

Can Indians buy Opko Health shares?

Yes, Indians can invest in the Opko Health (OPK) from India.

With INDmoney, you can buy Opko Health at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Opko Health at zero transaction cost.

How can I buy Opko Health shares from India?

It is very easy to buy Opko Health from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Opko Health be purchased?

Yes, you can buy fractional shares of Opko Health with INDmoney app.

What are the documents required to start investing in Opko Health stocks?

To start investing in Opko Health, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.